News & Events
Webcast: Crinetics Pharmaceuticals to Report Third Quarter 2025 Financial Results
Event Date: Crinetics company management will report third quarter 2025 financial results on Thursday, November 6, 2025 after the market closes.
READ MOREFDA Approval of PALSONIFY™ (paltusotine) for the Treatment of Adults with Acromegaly
Event Date: Crinetics will host an investor conference call on September 25, at 6:00 pm Eastern Time to discuss the FDA approval of PALSONIFY. Live & Archived Webcast: https://events.q4inc.com/attendee/443074040 Dial-in Details: Domestic: 1-833-470-1428International: 1-646-844-6383Conference ID: 120796
READ MOREWebcast: Crinetics Pharmaceuticals to Report Second Quarter 2025 Financial Results
Event Date: August 7, 2025
READ MORECrinetics Pharmaceuticals 2025 Annual Meeting of Stockholders
Event Date: June 11, 2025
READ MORECrinetics to Participate in the Jefferies Global Healthcare Conference 2025
Event Date: June 5, 2025
READ MORECrinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025
Event Date: June 5, 2025
READ MORECrinetics Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8
Event Date: May 8, 2025
READ MORECrinetics Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025
Event Date: Crinetics Pharmaceuticals to report first quarter 2025 financial results and provide a business update on May 8, 2025 after market close.
READ MORETransforming Endocrine Disease Treatment
Be the first to know about the advances we're making in endocrine-rooted care.
Email Signup
Please click CONTINUE below to learn more about a new treatment option. This website contains information about a prescription medicine.
